Chronic obstructive pulmonary disease: real opportunity of 3 year respiratory function control

I. Y. Vizel, E. A. Vizel, A. A. Vizel, E. Y. Pronina (Kazan, Russian Federation)

Source: Annual Congress 2006 - Implications of progressive airway obstruction
Session: Implications of progressive airway obstruction
Session type: Poster Discussion
Number: 3668
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. Y. Vizel, E. A. Vizel, A. A. Vizel, E. Y. Pronina (Kazan, Russian Federation). Chronic obstructive pulmonary disease: real opportunity of 3 year respiratory function control. Eur Respir J 2006; 28: Suppl. 50, 3668

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Chronic obstructive pulmonary disease (COPD) in children: is it possible?
Source: Eur Respir J 2005; 26: Suppl. 49, 63s
Year: 2005

Relationship between patient pulmonary function, exercise capacity and quality of life in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2012 - New issues in pulmonary function
Year: 2012

Pulmonary function in patients with chronic obstructive pulmonary disease (COPD) at the remote period after radiation exposure
Source: Eur Respir J 2007; 30: Suppl. 51, 338s
Year: 2007

Impact of a single chronic obstructive pulmonary disease (COPD) exacerbation on lung function decline: Analysis of UPLIFT®
Source: Annual Congress 2012 - Exacerbations of asthma and COPD: assessment, impact and novel treatments
Year: 2012

Chronic obstructive pulmonary disease: the patient perspective
Source: Eur Respir J 2001; 18: Suppl. 33, 401s
Year: 2001

Proactive integrated care improves quality of life in patients with COPD
Source: Eur Respir J 2009; 33: 1031-1038
Year: 2009



Chronic obstructive pulmonary disease (COPD) – patient‘s perspective
Source: Eur Respir J 2007; 30: Suppl. 51, 168s
Year: 2007

The year in chronic obstructive pulmonary disease
Source: International Congress 2018 – Clinical Year in Review
Year: 2018


Correlation between pulmonary function test (PFT) parameters and quality of life (QoL) and dyspnea in stable chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2007 - Clinical aspects in COPD
Year: 2007



Acute exacerbation of chronic obstructive pulmonary disease and antibiotics: what studies are still needed?
Source: Eur Respir J 2002; 19: 966-975
Year: 2002



Impact of exacerbations on COPD
Source: Eur Respir Rev 2009; 19: 113-118
Year: 2010



Self-medication at exacerbation of chronic obstructive pulmonary disease (COPD) is associated with faster recovery time
Source: Eur Respir J 2003; 22: Suppl. 45, 559s
Year: 2003

Chronic obstructive pulmonary disease (COPD) patients with bronchiectasis: clinical features?
Source: International Congress 2018 – COPD exacerbations and bronchiectasis
Year: 2018


Managing deteriorations in chronic obstructive pulmonary disease: which organ is failing?
Source: International Congress 2018 – Integrated care for patients with pulmonary vascular disease, lung diseases and heart failure
Year: 2018


Impact of exacerbations in the natural course of COPD
Source: Eur Respir Monogr 2013; 60: 84-95
Year: 2013


Can we predict the outcomes of treatment of patients with severe exacerbation of chronic obstructive pulmonary disease (COPD)?
Source: Eur Respir J 2001; 18: Suppl. 33, 241s
Year: 2001

The effect of dipyrone on respiratory function in chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2004; 24: Suppl. 48, 290s
Year: 2004

The respiratory microbiome in chronic obstructive pulmonary disease (COPD) exacerbations: Relationships with clinical characteristics
Source: Annual Congress 2012 - Hot topics in respiratory infections
Year: 2012

The food frequency in patients with chronic obstructive pulmonary disease: effect of exacerbation of disease
Source: Eur Respir J 2006; 28: Suppl. 50, 624s
Year: 2006